HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone Campus, Livingstone 10101, Zambia.
Vanderbilt University Medical Center, Department of Medicine, Division of Clinical Pharmacology, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.
Cells. 2023 May 9;12(10):1351. doi: 10.3390/cells12101351.
The development of antiretroviral drugs (ARVs) was a great milestone in the management of HIV infection. ARVs suppress viral activity in the host cell, thus minimizing injury to the cells and prolonging life. However, an effective treatment has remained elusive for four decades due to the successful immune evasion mechanisms of the virus. A thorough understanding of the molecular interaction of HIV with the host cell is essential in the development of both preventive and curative therapies for HIV infection. This review highlights several inherent mechanisms of HIV that promote its survival and propagation, such as the targeting of CD4 lymphocytes, the downregulation of MHC class I and II, antigenic variation and an envelope complex that minimizes antibody access, and how they collaboratively render the immune system unable to mount an effective response.
抗逆转录病毒药物(ARVs)的发展是 HIV 感染管理的一个重要里程碑。ARVs 抑制宿主细胞中的病毒活性,从而最大限度地减少对细胞的损伤并延长生命。然而,由于病毒成功的免疫逃逸机制,有效的治疗方法仍难以实现。深入了解 HIV 与宿主细胞的分子相互作用对于开发 HIV 感染的预防和治疗性疗法至关重要。这篇综述强调了 HIV 促进其存活和传播的几个固有机制,例如靶向 CD4 淋巴细胞、MHC Ⅰ类和Ⅱ类下调、抗原变异和最小化抗体进入的包膜复合物,以及它们如何协同作用使免疫系统无法产生有效反应。